4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001786335-26-000002
Chief Financial Officer sold 4,653 shares at $23.77 ($110,602)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Horn Howard · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-01 | Sale : show line 1 in the form 10b5-1 | −4,653 | $23.77 | $110,602 | 105,689 | D |
| Open-market sales · 4,653 sh · avg $23.77 · $110,602 | ||||||
Loading xslF345X06/ownership.xml…